Project Grant K23AI175676
Award Date
8/2/24
Completion Date
7/31/29
Dollars Obligated
$196K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This federal Project Grant award of $841,520 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to study microbial biomarkers that can predict multi-drug resistant organism (MDRO) colonization and infection in solid organ transplant recipients. The research leverages the awardee's existing cohort and biobank of over 2,200 samples from liver transplant patients to perform whole-genome sequencing of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $612,975.00 to fund research aimed at achieving long-term acceptance of organ transplants without the need for chronic immunosuppression. The research seeks to develop a translational model that combines T-cell costimulation blockade with inhibition of monocyte allorecognition via CD47 to induce long-term graft...
This Project Grant award, valued at $1,500,314 and awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on engineering a hydrogel-based human immune organoid to generate antigen-specific germinal center (GC) B cells and enable forced affinity maturation ex vivo. The goal is to examine the in vivo engraftment of the engineered human B cells delivered via injectable gels. This innovative...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $199,584 to Dr. Hyun Ah Yoon at the Albert Einstein College of Medicine to conduct research on antibody biomarkers for assessing risk of cryptococcosis in immunosuppressed solid organ transplant recipients. The key products and services to be delivered through this 5-year project include: 1) Retrospectively...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to identify immune factors that predict risk of cytomegalovirus (CMV) disease in orthotopic liver transplant recipients. The $832,910 award, effective May 9, 2025 through April 30, 2030, will support the University of Washington in characterizing the neutralizing and non-neutralizing antibody response as well as the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,442,898 to study the effects of vaccination on acute and post-acute respiratory viral infection outcomes in solid organ transplant recipients. The 5-year project, awarded to The Johns Hopkins University, aims to investigate the risks posed by respiratory viral infections, including SARS-CoV-2, RSV, and...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $300,000 Project Grant to Electronic Biosciences, Inc. to develop a novel point-of-care technology for monitoring immunosuppressant drug levels. The key product being developed is a portable, fingerstick-based testing system that can provide convenient and frequent immunosuppressant drug level measurements. This will enable more precise dosing for...
This federal Project Grant award for $775,986 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to mitigate cytomegalovirus (CMV) reactivation in kidney transplant recipients. The key objectives are to investigate the role of endoplasmic reticulum (ER) stress and mitochondrial (MT) dysfunction in triggering CMV reactivation following ischemia/reperfusion injury (IRI) to the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $891,678 to the Scripps Research Institute to conduct research on how metabolites from the intestinal microbiota can modulate host immune responses. The key objectives are to employ innovative chemical biology and proteomic methods to identify protein targets of microbiota-associated bile acids in mammalian...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $640,735.00 to Emory University to conduct research on understanding the mechanisms of CD8+ tissue-resident memory T cells (TRM) that mediate protection against respiratory virus transmission. The research aims to investigate the characteristics, durability, and molecular mechanisms of respiratory tract TRM...